Part: 12         Session: 123456789101112131415161718192021222324252627282930313233343536         Page 388389390391392393394395396397398399400401402403404405406407408 of 1143

other sources as well, but they've been aided by this effort.

In the case of arteriosclerosis, since 1950 we have known--even before, in ‘48, Wright's work had convinced me that anticoagulants cut the death rate someplace between 40 and 45 percent if given after a heart attack and his work has been widely confirmed, although every once in a while some group challenges the effectiveness of anticoagulants. However, just recently the work of Katz and Stammer in Chicago, which was supported by the National Heart Institute and by the Lasker Foundation, and the work of Marmostan and her group at the University of Southern California, which had support from the Lasker Foundation and large support from the Heart Institute and other sources, have shown that Premaron causes a drop of 50 percent in males that have had heart attack. Now, these figures are going to be verified by large studies of the Veterans Administration and of the National Heart Institute, and if they are verified, which I assume they will or something similar will be fond because I'm sure these two groups working independently can't be entirely wrong, this will be an immense new breakthrough, because it shows that one form of hormone has to do with the reversal of death in arteriosclerosis. In Marmostan's work she shows that it reduces the number of strokes as well.

So, we're on the fringes of getting some place, but there's still a terrible lot to do; this is just the beginning.

Well, I think that ought to be about it for the day.